🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In a The Breast Cancer Research Foundation webinar, Lola Fayanju (she/her, [email protected]) said that post-menopausal #BreastCancer is more likely in White women, but “more likely a Black woman will be diagnosed before they’ve begun regular screening and with a cancer that’s more biologically aggressive.” spr.ly/6013NFVeZ

Fantastic representation of #Thoracic oncology ASCO #ASCO25 posters! Ben Bleiberg Melina Marmarelis Corey Langer Lova Sun Penn Medicine - Abramson Cancer Center Penn Medicine MD Penn Medicine

Congratulations to these award-winning physicians! The future of @pennmedicine and @penncancer is indeed bright!

#ASCO25 Tune into the “Turning ‘Cold’ Tumors ‘Hot’” Clinical Science Symposium tomorrow morning to hear more from Stephen Bagley on CAR T cell therapy for recurrent #glioblastoma. Abstract 102. Penn Neurosurgery DrORourke

Our full P1 trial paper now available Nature Medicine for treatment of recurrent #Glioblastoma completed at Penn Medicine MD Penn Medicine - Abramson Cancer Center with support from Kite, a Gilead Company #cureGBM We see anti tumor responses and have defined dose for ICV #CART cells

#ASCO25: Stephen Bagley on CAR T cell for glioblastoma: “The treatment changed the trajectory of their disease.” Now in Nature Medicine and on the ASCO stage today. Abstract 102. DrORourke spr.ly/6018N7k16

#PC3IatASCO: Gabriel Aleixo, Ramy Sedhom, MD, FASCO, Efrat Dotan MD, & Ravi B. Parikh evaluating implementation of the Practical #Geriatric Assessment & resulting #chemotherapy dose modification among older adults with #cancer. #ASCO25 ASCO meetings.asco.org/abstracts-pres… pc3i.upenn.edu/news/pc3i-pres…

Congrats Stephen Bagley DrORourke and colleagues Penn Medicine - Abramson Cancer Center on their manuscript in Nature Medicine showing safety and early efficacy of bivalent CAR T cells in 18 patients with recurrent #glioblastoma! nature.com/articles/s4159…

#ASCO25 Vivek Narayan shares key takeaways from the five-year follow-up of the LITEPARK-004 study of Belzutifan for VHL. in Hall D2. Abstract 4507. Penn Medicine - Abramson Cancer Center

#ASCO25 In a phase I study, dual-targe CAR T cell therapy was safe, feasible, and slowed the growth of recurrent glioblastoma, with tumor regressions in 62% of patients. Abstract 102. Stephen Bagley DrORourke Nature Medicine spr.ly/6013N7me7

New in Nature Medicine, our researchers have found that a dual-target CAR T-cell therapy approach shows promise for slowing tumor growth in glioblastoma. Stephen Bagley DrORourke Penn Medicine - Abramson Cancer Center Penn Medicine ➡️ spr.ly/6011NCoGT

Visit Penn Medicine - Abramson Cancer Center at #ASCO25 at booth #11000 to learn about job opportunities and advances in oncology taking place at Penn Medicine. We're hiring in Philly, Lancaster, and Princeton!

Join us either in person or virtually for the Updates in Oncology 2025 meeting on 6/11, which will address the questions that have emerged from the latest data presented at major international annual meetings. Learn more and register here: spr.ly/6019NfiRX

The best thoracic/HN section! So grateful to work with each one of these fabulous individuals ASCO #ASCO25 Penn Medicine Penn Medicine - Abramson Cancer Center Penn Medicine MD

Staci Kallish, DO, part of the Penn Aorta Center, highlights the importance of identifying monogenic causes of aortic disease to guide monitoring specific blood vessels, surgical decisions, and screening at-risk family members. Penn Cardiology spr.ly/6019NCN4b

Last night at the Penn Medicine - Abramson Cancer Center reception! Wonderful representation ASCO #ASCO25 and we had with several faculty, fellows, alumni presenting science that can change practice! Penn Medicine MD Penn Medicine

🚨 Don’t miss our educational session today! 📍 E450A, 8 AM CT 🎤 Kaushal Parikh Biagio Ricciuti, MD, PhD ASCO #ASCO25 OncoAlert #LCSM

ICYMI ➡️ recent Penn Medicine clinical trials found that asynchronous semiautomated referrals for pharmacist involvement in lipid management could be a scalable approach for increasing #statin prescribing. Here's why 👇 spr.ly/6015NxOuP #Pharmarceuticals #Cardiology

#ASCO25 Does neoadjuvant immunotherapy have a place in earlier-stage melanoma? Giorgos Karakousis, MD, shares the results of a Phase II study on the closing day of ASCO. Abstract 9502. @PennMedMelanoma @PennSurgery

Last week, Penn Aorta Center Director Dr. Desai and Vascular Director Dr. Wang hosted an Aorta Summit Dinner Meeting sharing expertise, resources, and the opportunity to collaborate in comprehensive aortic disease patient care @penncardiology PennSurgery